MORGAN STANLEY

Position in VSTM — Verastem, Inc.

CIK 895421 NEW YORK, NY

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$11,910,543

-$2,537,912 QoQ

Shares Held

2,247,273

+20.1% QoQ

Ownership

2.56%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 99.18238683061648.ToString("F0")% Shared 0.ToString("F0")% None 0.817613169383515.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. VSTM ranks #123 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,910,543	2,247,273	+20.1%	Shares	Defined	2026-05-15
2025-12-31	$14,448,455	1,871,562	+18.5%	Shares	Defined	2026-05-27
2025-09-30	$13,946,859	1,579,486	+41.1%	Shares	Defined	2026-05-27
2025-06-30	$4,646,985	1,119,756	-3.0%	Shares	Defined	2025-08-15
2025-03-31	$6,963,381	1,154,790	+42.2%	Shares	Defined	2025-05-15
2024-12-31	$4,197,987	811,990	+370.0%	Shares	Defined	2025-05-15
2024-09-30	$516,529	172,753	+3.9%	Shares	Defined	2025-05-14
2024-06-30	$495,345	166,224	+205.7%	Shares	Defined	2025-05-14
2024-03-31	$641,648	54,377	-62.1%	Shares	Defined	2024-10-17
2023-12-31	$1,168,903	143,600	+1189.2%	Shares	Defined	2024-08-16
2023-09-30	$90,559	11,139	-49.8%	Shares	Defined	2023-11-15
2023-06-30	$165,241	22,210	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.